Rollins Total Cost of Revenue decreased by 0.5% to $445.52M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.3%, from $400.13M to $445.52M. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 11.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $297.86M | $305.47M | $297.73M | $295.38M | $336.78M | $348.16M | $328.08M | $326.84M | $384.19M | $388.53M | $370.31M | $365.56M | $410.29M | $421.89M | $405.46M | $400.13M | $461.86M | $467.45M | $447.56M | $445.52M |
| QoQ Change | — | +2.6% | -2.5% | -0.8% | +14.0% | +3.4% | -5.8% | -0.4% | +17.5% | +1.1% | -4.7% | -1.3% | +12.2% | +2.8% | -3.9% | -1.3% | +15.4% | +1.2% | -4.3% | -0.5% |
| YoY Change | — | — | — | — | +13.1% | +14.0% | +10.2% | +10.7% | +14.1% | +11.6% | +12.9% | +11.8% | +6.8% | +8.6% | +9.5% | +9.5% | +12.6% | +10.8% | +10.4% | +11.3% |
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Reportable Segment | $400.13M | $461.86M | $467.45M | $447.56M | $445.52M |
| Total | $400.13M | $461.86M | $467.45M | $447.56M | $445.52M |